EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Treatment of severe osteogenesis imperfecta by allogeneic bone marrow transplantation



Treatment of severe osteogenesis imperfecta by allogeneic bone marrow transplantation



Matrix Biology 15(3): 188




(PDF emailed within 0-6 h: $19.90)

Accession: 034071109

Download citation: RISBibTeXText

DOI: 10.1016/s0945-053x(96)90086-4



Related references

Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta. Blood 97(5): 1227-1231, 2001

Bone Marrow Transplantation for Treatment of the Col1a2+/G610C Osteogenesis Imperfecta Mouse Model. Calcified Tissue International 2018, 2018

Ex Vivo Expanded Allogeneic Mesenchymal Stem Cells With Bone Marrow Transplantation Improved Osteogenesis in Infants With Severe Hypophosphatasia. Cell Transplantation 24(10): 1931-1943, 2016

Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proceedings of the National Academy of Sciences of the United States of America 99(13): 8932-8937, 2002

Transplanted allogeneic gene-marked marrow mesenchymal cells engraft and benefit children with severe osteogenesis imperfecta. Blood 96(11 Part 1): 800a, November 16, 2000

Bone marrow transplantation to correct the mesenchymal defect of children with osteogenesis imperfecta. Blood 90(10 SUPPL 1 PART 1): 230A-231A, Nov 15, 1997

Treatment of 144 patients with severe aplastic anemia using immunosuppression and allogeneic marrow transplantation: a report from the international bone marrow transplant registry. Transplantation Proceedings 13(1 Pt 1): 227-229, 1981

Severe acquired aplastic anemia: historical outcome of patients treated by allogeneic bone marrow transplantation from matched sibling donors. A study by the Spanish Group for Bone Marrow Transplantation in Children (GETMON). Anales de Pediatria 69(1): 5-9, 2008

Engraftment and clinical benefit from bone marrow mesenchymal cell transplantation for children with osteogenesis imperfecta. Blood 94(10 SUPPL 1 PART 1): 609a, Nov 15, 1999

In utero transplantation of adult bone marrow decreases perinatal lethality and rescues the bone phenotype in the knockin murine model for classical, dominant osteogenesis imperfecta. Blood 114(2): 459-468, 2009

Conservative treatment of severe haemorrhagic cystitis following allogeneic bone marrow transplantation. European Urology Supplements 2(1): 17, February, 2003

Treatment of severe thrombasthenia combined with pyknodysostosis by allogeneic bone marrow transplantation. Onkologie 14(SUPPL 2): 153, 1991

Severe aplastic anemia: allogeneic bone marrow transplantation as first-line treatment. Blood Advances 2(15): 2020-2028, 2018

Treatment of moderate and severe acute GVHD after allogeneic bone marrow transplantation. Transplantation 58(4): 437-442, 1994

Allogeneic bone marrow transplantation versus autologous bone marrow transplantation for the treatment of childhood acute after early marrow relapse. Bone Marrow Transplantation 18(SUPPL 3): S64, 1996